IMAC (BACK) Competitors $0.08 +0.01 (+11.69%) As of 03:06 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock BACK vs. OTRK, BTTX, UPHL, OPGN, ACONW, AONC, DHACW, FMS, LFMDP, and PIIIWShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Ontrak (OTRK), Better Therapeutics (BTTX), UpHealth (UPHL), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry. IMAC vs. Its Competitors Ontrak Better Therapeutics UpHealth OpGen Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD P3 Health Partners Ontrak (NASDAQ:OTRK) and IMAC (NASDAQ:BACK) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk. Which has stronger valuation & earnings, OTRK or BACK? IMAC has lower revenue, but higher earnings than Ontrak. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOntrak$10.18M0.01-$25.49M-$15.810.00IMAC$72.05K2.17-$9.42MN/AN/A Which has more volatility & risk, OTRK or BACK? Ontrak has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Comparatively, IMAC has a beta of 2.32, indicating that its share price is 132% more volatile than the S&P 500. Does the media refer more to OTRK or BACK? In the previous week, IMAC had 2 more articles in the media than Ontrak. MarketBeat recorded 2 mentions for IMAC and 0 mentions for Ontrak. IMAC's average media sentiment score of 0.46 beat Ontrak's score of 0.00 indicating that IMAC is being referred to more favorably in the news media. Company Overall Sentiment Ontrak Neutral IMAC Neutral Is OTRK or BACK more profitable? IMAC has a net margin of 0.00% compared to Ontrak's net margin of -274.20%. IMAC's return on equity of 0.00% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets Ontrak-274.20% -269.88% -128.35% IMAC N/A N/A -325.44% Do analysts prefer OTRK or BACK? Ontrak presently has a consensus target price of $3.00, indicating a potential upside of 13,536.36%. Given Ontrak's stronger consensus rating and higher probable upside, research analysts plainly believe Ontrak is more favorable than IMAC.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00IMAC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals have more ownership in OTRK or BACK? 12.9% of Ontrak shares are held by institutional investors. Comparatively, 5.8% of IMAC shares are held by institutional investors. 1.9% of Ontrak shares are held by insiders. Comparatively, 12.3% of IMAC shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryIMAC beats Ontrak on 8 of the 14 factors compared between the two stocks. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BACK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BACK vs. The Competition Export to ExcelMetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$156K$156K$6.13B$10.46BDividend YieldN/AN/A5.73%4.78%P/E RatioN/AN/A85.1527.20Price / Sales2.172.17574.61178.68Price / CashN/AN/A37.3961.86Price / Book-0.11N/A12.396.65Net Income-$9.42M-$9.42M$3.32B$276.79M7 Day PerformanceN/AN/A-0.24%-1.51%1 Month PerformanceN/AN/A9.56%5.46%1 Year PerformanceN/AN/A71.67%36.25% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BACKIMACN/A$0.08+11.7%N/A-94.0%$156K$72.05K0.00180Positive NewsGap UpOTRKOntrak1.4769 of 5 stars$0.02-24.9%$3.00+13,536.4%-99.1%$93K$10.18M0.00250Gap DownBTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.6%$4K$130M0.001,750OPGNOpGenN/AN/AN/A-100.0%$1K$2.67M0.00100ACONWAclarionN/A$0.03+14.0%N/A+108.7%$0.00$62.95K0.007Gap DownAONCAmerican Oncology NetworkN/A$8.83+3.5%N/A+185.9%$0.00$1.34B0.001,520Short Interest ↓DHACWDigital Health AcquisitionN/A$0.02+13.3%N/A-31.3%$0.00N/A0.00N/AGap UpFMSFresenius Medical Care AG & Co. KGaA4.3079 of 5 stars$27.07+0.9%$27.80+2.7%+33.1%$0.00$20.63B22.191,384News CoveragePositive NewsAnalyst DowngradeShort Interest ↓LFMDPLifeMDN/A$23.71+1.0%N/A+7.8%$0.00$245.56M0.00230Short Interest ↓PIIIWP3 Health PartnersN/A$0.01+7.6%N/A-60.7%$0.00$1.46B0.00500Gap DownHigh Trading Volume Related Companies and Tools Related Companies Ontrak Competitors Better Therapeutics Competitors UpHealth Competitors OpGen Competitors Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors Fresenius Medical Care AG & Co. KGaA Competitors LifeMD Competitors P3 Health Partners Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BACK) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
